España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Akoya Biosciences
AKYA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.49
-0.06
-2.35%
At close: -
$2.49
0.00
0.00%
After Hours: Dec 20, 4:05 PM EDT
Get Report
Comment
Akoya Biosciences (AKYA) Forecast
News
Earnings
Akoya Biosciences (AKYA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Akoya Biosciences (NASDAQ:AKYA) Stock
Akoya Biosciences Stock (NASDAQ: AKYA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 10, 2024
Akoya Biosciences shares are trading higher a...
Benzinga Newsdesk
Akoya Biosciences And NeraCare Sign Exclusive...
Benzinga Newsdesk
Tuesday, November 19, 2024
Piper Sandler Reiterates Overweight on Akoya ...
Benzinga Newsdesk
Friday, November 15, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Craig-Hallum Downgrades Akoya Biosciences to ...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Akoya Bios...
Benzinga Newsdesk
Akoya Biosciences shares are trading lower af...
Benzinga Newsdesk
Thursday, November 14, 2024
Akoya Biosciences shares are trading lower af...
Benzinga Newsdesk
Akoya Biosciences Sees FY24 Revenue $80M-$104...
Benzinga Newsdesk
Akoya Biosciences Q3 2024 GAAP EPS $(0.21) Mi...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, October 09, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, October 07, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Akoya BioSciences shares are trading higher a...
Benzinga Newsdesk
Akoya's Leading Spatial Proteomics Platforms ...
Benzinga Newsdesk
Thursday, October 03, 2024
Akoya Biosciences Announces Scott Mendel Appo...
Benzinga Newsdesk
Tuesday, August 13, 2024
Piper Sandler Maintains Overweight on Akoya B...
Benzinga Newsdesk
Tuesday, August 06, 2024
Morgan Stanley Downgrades Akoya Biosciences t...
Benzinga Newsdesk
BTIG Downgrades Akoya Biosciences to Neutral
Benzinga Newsdesk
A Closer Look at 4 Analyst Recommendations For Akoya Biosciences
Benzinga Insights
Craig-Hallum Maintains Buy on Akoya Bioscienc...
Benzinga Newsdesk
JP Morgan Downgrades Akoya Biosciences to Neu...
Benzinga Newsdesk
Monday, August 05, 2024
Akoya Biosciences Sees FY24 Revenue $96M-$104...
Benzinga Newsdesk
Akoya Biosciences Q2 2024 GAAP EPS $(0.27), I...
Benzinga Newsdesk
Monday, June 03, 2024
Analyst Scoreboard: 4 Ratings For Akoya Biosciences
Benzinga Insights
Morgan Stanley Maintains Overweight on Akoya ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Canaccord Genuity Maintains Buy on Akoya Bios...
Benzinga Newsdesk
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Akoya BioSciences shares are trading lower af...
Benzinga Newsdesk
BTIG Maintains Buy on Akoya Biosciences, Lowe...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, May 13, 2024
Akoya Biosciences Cuts FY24 Revenue Forecast ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Akoya BioSciences shares are trading lower af...
Benzinga Newsdesk
Akoya Biosciences Q1 2024 Adj EPS $(0.39) Mis...
Benzinga Newsdesk
Thursday, May 09, 2024
Akoya Biosciences And NeraCare Enter Exclusiv...
Benzinga Newsdesk
Thursday, May 02, 2024
Akoya Biosciences And Shanghai KR Pharmtech A...
Benzinga Newsdesk
Wednesday, March 06, 2024
JP Morgan Maintains Overweight on Akoya Biosc...
Benzinga Newsdesk
Tuesday, March 05, 2024
UBS Maintains Buy on Akoya Biosciences, Raise...
Benzinga Newsdesk
Canaccord Genuity Reiterates Buy on Akoya Bio...
Benzinga Newsdesk
Monday, March 04, 2024
Akoya Biosciences Sees FY24 Revenue $114M-$11...
Benzinga Newsdesk
Recap: Akoya Biosciences Q4 Earnings
Benzinga Insights
Akoya Biosciences Q4 2023 GAAP EPS $(0.22) Be...
Benzinga Newsdesk
Earnings Scheduled For March 4, 2024
Benzinga Insights
Friday, March 01, 2024
Earnings Outlook For Akoya Biosciences
Benzinga Insights
Sunday, January 07, 2024
Akoya Biosciences Announces Preliminary Finan...
Benzinga Newsdesk
Akoya Biosciences Announced Earlier Sunday, It Deployed The Maxfuse Algorithm Co-developed By Dr. Garry Nolan And His Laboratory At Stanford University For Multiomic Integration Of Spatial And Single-cell Data On The Enable Medicine Platform
Charles Gross
Akoya Biosciences And Thermo Fisher Scientific Announced Earlier Sunday, A License And Distribution Agreement To Deliver Spatial Multiomics Workflow
Charles Gross
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch